Paper Details 
Original Abstract of the Article :
The safety of pharmacotherapy in atrial fibrillation (AF) is compounded by a trilogy of risks old age, high-risk medications (e.g., antithrombotics, antiarrhythmics), polypharmacy due to multiple patient comorbidities. However, to date, scarce study has investigated the use of polypharmacy (includin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930859/

データ提供:米国国立医学図書館(NLM)

A Trilogy of Risks: Navigating Medication Safety in Atrial Fibrillation

Atrial fibrillation, a condition that affects the heart's rhythm, is like a desert mirage, appearing alluring but potentially dangerous. Managing this condition often involves medications, but these treatments can be complex for older patients, especially those with multiple health issues. This research examines the challenges of medication safety in older patients with atrial fibrillation, highlighting the 'trilogy' of risks: old age, high-risk medications, and polypharmacy (taking multiple medications). It's like navigating a desert filled with hidden dangers, each one adding to the complexity of the journey.

Polypharmacy and Atrial Fibrillation: A Complex Landscape

The study emphasizes the lack of research on polypharmacy in atrial fibrillation, a crucial area for understanding potential risks and optimizing medication management. It's like exploring a vast desert with an inadequate map, making the journey more challenging and uncertain. This research calls for further investigation into the impact of polypharmacy on medication safety in this patient population.

A Call for Vigilance: Addressing Medication Risks in Older Patients

This research underscores the importance of careful medication management for older patients with atrial fibrillation. It's like a desert guide cautioning travelers to be aware of hidden dangers and take necessary precautions. Close monitoring, open communication with healthcare providers, and a thorough understanding of medications are crucial to ensure safe and effective treatment.

Dr.Camel's Conclusion

Medication management in older patients with atrial fibrillation is a complex desert landscape filled with hidden dangers. This research is a call to action, encouraging further exploration of this intricate terrain to find safe and effective solutions. Remember, when navigating a desert, it's essential to be prepared, informed, and vigilant to avoid potential pitfalls. This study is a reminder that even with the best intentions, we must remain aware of the challenges and seek out new knowledge to guide us through.

Date :
  1. Date Completed 2016-07-06
  2. Date Revised 2022-03-17
Further Info :

Pubmed ID

27382425

DOI: Digital Object Identifier

PMC4930859

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.